Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
2 reports, 1 independent
Updated Aug 27
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Monopar Therapeutics received research reports and ratings from Cantor Fitzgerald and Morgan Stanley.1 source
Analyst ratings published on MarketBeat for Monopar Therapeutics.1 source
Keep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Monopar Therapeutics
biopharmaceutical company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- MarketBeat provides ratings for listed companies.
- Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.
- MarketBeat reported analyst recommendations, noting that both MarketBeat and Jefferies Financial Group are mid-cap finance companies.
- MarketBeat reports on company ratings and targets for Nikon Corporation and Jabil, comparing business profiles and financial health.
- MarketBeat provided analyst ratings for CPS Technologies Corp. on October 22, 2026.